A new strategy for enhancing the production of protein-based drugs

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.

MarketingRx roundup: Analyst group finds no ‘obvious’ link to GLP-1s and suicidal ideation; Amgen debuts new Prolia TV ad

Last month, the European Medicines Agency began looking into reports of suicidal ideation and thoughts of self-harm by users of GLP-1 medicines such as Novo

August 9, 2023

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital | Psychedelic Finance

LONDON, July 05, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental

July 7, 2023

Triple-drug chemo fails to improve survival in advanced biliary tract cancer

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology showed

January 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.